Repare Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy RPTX

*Your capital is at risk

$2.65

+0 (+0%)

At Close: Apr 24, 2026

Repare Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 18.25. In total, the insiders bought 3.4M and sold 1.76M RPTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	18.25
● Buy	3.4M shares
● Sell	1.76M shares
54% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jan 28, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 04, 2025 Buy	Employee Stock Option (right to buy) A-Award	Forte Steve EVP, Chief Financial Officer	C-Suite Officer	200 000 Value: $234.0K
Mar 04, 2025 Buy	Employee Stock Option (right to buy) A-Award	Zinda Michael EVP, Chief Scientific Officer	Officer	75 000 Value: $87.8K
Mar 04, 2025 Buy	Employee Stock Option (right to buy) A-Award	Zinda Michael EVP, Chief Scientific Officer	Officer	85 000 Value: $99.5K
Mar 04, 2025 Buy	Common Shares A-Award	Zinda Michael EVP, Chief Scientific Officer	Officer	14 000 Value: $16.4K
Mar 04, 2025 Buy	Common Shares A-Award	Segal Lloyd Mitchell President And CEO	CEO / President	40 000 Value: $46.8K
Mar 04, 2025 Buy	Employee Stock Option (right to buy) A-Award	Segal Lloyd Mitchell President And CEO	CEO / President	237 000 Value: $277.3K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Schafer Carol Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Rhoads Ann D Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Morrison Briggs Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Molineaux Susan Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Kulkarni Samarth Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Bonita David P Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Civik Thomas Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Stein Steven H Director	Director	54 000 Value: $205.2K
Jun 17, 2024 Buy	Common Stock J-Other	Stein Steven H Insider	Other	0 Value: $0
Jun 17, 2024 Buy	Common Stock J-Other	Stein Steven H Insider	Other	0 Value: $0
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Stein Steven H Director	Director	54 000 Value: $205.2K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Civik Thomas Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Bonita David P Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Kulkarni Samarth Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Molineaux Susan Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Morrison Briggs Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Rhoads Ann D Director	Director	27 200 Value: $103.4K
Jun 17, 2024 Buy	Stock Option (right to buy) A-Award	Schafer Carol Director	Director	27 200 Value: $103.4K
Apr 01, 2024 Sell	Common Shares S-Sale	Segal Lloyd Mitchell President And CEO	CEO / President	2 491 Value: $11.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT REPARE THERAPEUTICS INC.

Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an ora...

Read Full Profile Here